Veterinary Orthopedics Market

The veterinary orthopedics market is projected to reach USD 0.86 billion by 2031 from USD 0.57 billion in 2026, growing at a CAGR of 8.5% during the forecast period.

Growth in the veterinary orthopedics market is largely driven by the rise in pet cases involving musculoskeletal disorders, trauma, and degenerative joint disease. Additionally, growing pet ownership, driven by a trend toward humanization, is fueling this expansion. Cranial cruciate ligament tears, hip dysplasia, osteoarthritis, and various types of fractures are becoming more recognized due to increased awareness, advanced diagnostic imaging techniques, and a higher number of pet consultations with veterinarians. This growing recognition is driving demand for specialized orthopedic procedures, including fracture fixation, joint-stabilizing surgery, and corrective bone surgery, which, in turn, is increasing interest in veterinary orthopedic implants, instruments, and consumables.

To know about the assumptions considered for the study download the pdf brochure

Additionally, pet owners are spending more on their pets, allowing for more advanced surgical options. Rising veterinary costs and a trend toward specialized veterinary practices in referral clinics are also contributing to this growth. Innovations in implant materials, anatomically contoured fixation systems, minimally invasive surgical techniques, and precision surgical tools are continuously enhancing clinical outcomes and driving further interest in the field.

The prominent players in the veterinary orthopedics market are Movora (Switzerland), Arthrex, Inc. (US), DePuy Synthes (Johnson & Johnson) (US), Securos Surgical (Cencora Inc.) (US), and Orthomed (UK) Ltd. (UK), among others. These companies have implemented a variety of growth strategies, both organic and inorganic, including introducing new products, forming strategic partnerships, and entering emerging markets. These initiatives aim to enhance their market share and diversify their portfolios.

In July 2025, Movora entered an exclusivity agreement with Aesculap (a division of B. Braun VetCare) to become the sole distributor of Aesculap Surgical Power Systems and related power accessories in the US and Canada. This strategic partnership enhances Movora’s veterinary orthopedic and surgical product offerings and ensures broader access to advanced surgical power tools for veterinary professionals across North America, along with streamlined service and support.

In February 2025, Orthomed launched NXP (The Nexus Pin), a new intramedullary pin technology designed to simplify long bone fracture repair in veterinary orthopedics. The Nexus Pin offers improved fracture alignment, stability, and anti-migration features, integrates with existing surgical techniques, and supports effective treatment of complex fractures in bones such as the tibia, femur, and humerus.

Movora is a global veterinary medical technology company specializing in orthopedic solutions and surgical instruments for companion animals. Movora operates as the MedTech vertical of the Vimian Group. Movora’s offerings are organized into a family of brands that cover a broad range of veterinary orthopedic and surgical solutions. These include BioMedtrix (total joint replacement and implant systems), KYON (orthopedic implants and instruments, including TPLO, TTA, and THR), IMEX Veterinary (external fixation and VetKISS micro plating systems), Veterinary Orthopaedic Implants (comprehensive orthopedic plating, power equipment, and instruments), and other specialized lines such as NGD, VetSpectrum instruments, VetPower surgical power systems, VetClarity imaging solutions, and Veterinary Transplant Services. Movora maintains a global presence with operational reach across multiple continents. The company has established regional headquarters and distribution infrastructure in the Americas, Europe, and Asia, supporting broad access to its product portfolio and education services. Movora’s global footprint is further extended through acquisitions and integration of regional veterinary suppliers such as IMEX Veterinary in the US, Freelance Surgical in the UK, and Kahuvet (Knight Benedikt) in Oceania, enabling localized distribution and tailored customer support.

Cencora operates through two reportable segments: U.S. Healthcare Solutions (comprising Human Health and Animal Health) and International Healthcare Solutions.Securos Surgical operates within Cencora’s U.S. Healthcare Solutions segment, specifically under the Animal Health division (MWI Animal Health), as the company’s dedicated veterinary orthopedic and surgical solutions brand. Securos Surgical is a specialized veterinary medical device company that designs, engineers, and supplies high-quality orthopedic implants, surgical instruments, sutures, and related solutions for animal health professionals. Securos Surgical’s product portfolio is structured around a range of veterinary surgical solutions with a strong emphasis on orthopedic systems and support technologies. The core segments include Veterinary Orthopedics, Surgical Instruments, and Sutures. The company offers veterinary orthopedic products through the Veterinary Orthopedics segment. This segment offers implants and fixation systems, such as the Surg’X Interlocking Nail System, locking trauma and joint management plating systems, and cannulated bone screw systems tailored for animal musculoskeletal procedures. The Surgical Instruments segment offers premium surgical instrument lines designed especially for veterinary surgeons, including orthopedic instrument sets. The Sutures segment offers a comprehensive range of suture options with industry-leading tensile strength and performance for soft-tissue closure in surgical procedures. Securos Surgical is headquartered in Fiskdale, Massachusetts, US, and maintains a presence in key international markets, including Europe (Tuttlingen, Germany) and the UK, where it operates local offices and training facilities. Through its integration with Cencora, Inc.—a major global healthcare distribution network—Securos Surgical benefits from extensive distribution channels that make its orthopedic implants, instruments, and sutures available to veterinarians in North America, Europe, and other global regions.

Market Ranking

The top five companies in the veterinary orthopedics market account for 77–87% of the market share. Movora (Switzerland) leads the industry with its diversified and specialized range of veterinary orthopedic implants, instruments, and fixation devices. The company also offers comprehensive educational programs for surgeons and maintains strong worldwide distribution networks.

Following Movora is Securos Surgical (Cencora Inc., US), which offers a diverse selection of orthopedic and soft-tissue surgery products at competitive prices. DePuy Synthes (Johnson & Johnson, US) stands out with its advanced technological transfers from its orthopedic human medical products division. This company boasts a diversified portfolio of advanced trauma and fixation devices specifically designed to address veterinary needs, backed by significant investments in research and development and manufacturing expertise.

Arthrex (US) has established a strong presence with its broad array of minimally invasive and arthroscopy-based orthopedic solutions, particularly in ligament reconstruction and joint stabilization procedures. Lastly, Orthomed (UK) has positioned itself as a key player in the veterinary orthopedics sector with its varied product portfolio.

Related Reports:

Veterinary Orthopedics Market by Product (Orthopedic Implants, Instruments, Consumables), Animal Type (Dog, Cat, Horse, Livestock), Application (TPLO, TTA, Fracture Repair), Material (Metallic, Absorbable), End User, and Region - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com